TY - JOUR
T1 - African Americans’ discussions about living-donor kidney transplants with family or friends
T2 - Who, what, and why not?
AU - DePasquale, Nicole
AU - Ellis, Matthew J.
AU - Sudan, Debra L.
AU - Ephraim, Patti L.
AU - McElroy, Lisa M.
AU - Mohottige, Dinushika
AU - Davenport, Clemontina A.
AU - Zhang, Xiyuan
AU - Peskoe, Sarah B.
AU - Strigo, Tara S.
AU - Cabacungan, Ashley N.
AU - Pounds, Iris
AU - Riley, Jennie A.
AU - Falkovic, Margaret
AU - Boulware, L. Ebony
N1 - Publisher Copyright:
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
PY - 2021/4
Y1 - 2021/4
N2 - Background: Although discussions with family or friends can improve access to living-donor kidney transplantation (LDKT), they remain an understudied step in the LDKT process. Methods: Among 300 African American transplant candidates, we examined how sociodemographic, clinical, LDKT-related, and psychosocial characteristics related to the occurrence of LDKT discussions with family or friends. We also analyzed the relation between discussion occurrence and donor activation on transplant candidates’ behalves (at least one donor inquiry or completed donor evaluation in the medical record). We assessed associations of discussion characteristics (context, content, and perceptions) with donor activation among discussants, and we identified discussion barriers among non-discussants. Results: Most candidates (90%) had discussed LDKT. Only family functioning was statistically significantly associated with discussion occurrence. Specifically, family dysfunction was associated with 62% lower odds of discussion than family function. Family functioning, discussion occurrence, and different discussion characteristics were statistically significantly related to donor activation. The most prevalent discussion barrier was never having thought about discussing LDKT. Conclusions: Family functioning affected the likelihood of discussing LDKT, and family functioning, discussion occurrence, and discussion characteristics were associated with donor activation. Advancing understanding of how family functioning and LDKT discussions affect progression to LDKT may benefit interventions to increase LDKT.
AB - Background: Although discussions with family or friends can improve access to living-donor kidney transplantation (LDKT), they remain an understudied step in the LDKT process. Methods: Among 300 African American transplant candidates, we examined how sociodemographic, clinical, LDKT-related, and psychosocial characteristics related to the occurrence of LDKT discussions with family or friends. We also analyzed the relation between discussion occurrence and donor activation on transplant candidates’ behalves (at least one donor inquiry or completed donor evaluation in the medical record). We assessed associations of discussion characteristics (context, content, and perceptions) with donor activation among discussants, and we identified discussion barriers among non-discussants. Results: Most candidates (90%) had discussed LDKT. Only family functioning was statistically significantly associated with discussion occurrence. Specifically, family dysfunction was associated with 62% lower odds of discussion than family function. Family functioning, discussion occurrence, and different discussion characteristics were statistically significantly related to donor activation. The most prevalent discussion barrier was never having thought about discussing LDKT. Conclusions: Family functioning affected the likelihood of discussing LDKT, and family functioning, discussion occurrence, and discussion characteristics were associated with donor activation. Advancing understanding of how family functioning and LDKT discussions affect progression to LDKT may benefit interventions to increase LDKT.
KW - communication
KW - discussion barriers
KW - donor activation
KW - living kidney donation
UR - http://www.scopus.com/inward/record.url?scp=85099970711&partnerID=8YFLogxK
U2 - 10.1111/ctr.14222
DO - 10.1111/ctr.14222
M3 - Article
C2 - 33423353
AN - SCOPUS:85099970711
SN - 0902-0063
VL - 35
JO - Clinical Transplantation
JF - Clinical Transplantation
IS - 4
M1 - e14222
ER -